ImaBiotech website in English


  • ASMS 2017

    Come and meet Rima Ait-Belkacem and Jonathan Stauber to discover all our capabilities. June 4- 8, 2017, in (...)

    Read more
  • Webinar on Immuno-Oncology by Rima AIT-BELKACEM, PhD

    The webinar titled “Immuno-Oncology: Tryptophan-Kynurenine Microenvironment Tumor Metabolites Pathway Highlighted by (...)

    Read more
See all news


In just a few days, evaluate and compare drug distribution and concentration in various parts of the intestine.

ImaBiotech provides quantitative MALDI Imaging Mass Spectrometry services unmatched

by any other classical technique: quantitative label-free drug distribution in gastroenterology studies with high accuracy up to 20µm resolution.

Classical drug pharmacokinetics and distribution with dissection can now be advantageously replaced by MALDI Imaging Mass Spectrometry allowing the accurate localization and quantitation of parent drug and metabolites. No LCMS/MS method development for each specific Intestine tissue!

Gastroenterology Mass spectrometry Imaging
Figure : Optical and MALDI Mass Spectrometry Images of the colon in a mouse treated with a drug candidate via oral administration. Section thickness: 12 µm; spatial resolution: 30 µm.

In Gastroenterology, we can study :
_ Target Engagement


MSI Toxicology Maldi Toxicity effects

Drug distribution and quantification
  • High resolution drug and metabolites imaging at 20µm
  • Quantify drug and metabolites in different regions of the gastrointestinal tract
  • Coupled with whole body distribution to study overall and organ-specific localization
  • Unknown metabolite research and identification

  • Gastroenteritis
  • IBS - IBD
  • Crohn’s disease

Regions of interest
  • Ileum
  • Jejunum
  • Duodenum
  • Colon
  • Mucosa
  • Submucosa
  • Brunner glands

Animal species
  • Rat
  • Mouse

  • Study the impact of treatment onto endogenous metabolites
  • Support the validation of pharmacological animal models